Skip to main content
. 2012 Jul 2;39(3):684–691. doi: 10.1093/schbul/sbs071

Table 1.

Demographics and Clinical Characteristics

Patients
Controls Placebo 25 µg Clonidine 50 µg Clonidine 75 µg Clonidine 150 µg Clonidine
Mean age (SEM) 36.5 y (1.5) 37.5 y (1.4)
Average PANSS scores (SEM)
Positive 13.0 (1.2) 14.0 (1.6) 12.7 (1.1) 13.8 (1.6) 12.5 (0.9)
Negative 14.3 (1.2) 15.6 (1.0) 15.4 (1.4) 15.4 (1.2) 14.3 (1.1)
General 25.4 (1.6) 27.1 (1.9) 25.1 (1.7) 25.7 (1.6) 24.4 (1.2)
Total 52.6 (3.4) 56.1 (3.4) 53.1 (3.4) 54.8 (3.9) 50.8 (2.4)

Note: Characteristics of patients and matched healthy controls, showing no significant differences in age between patients and controls, nor significant differences in PANSS scores in the patients over the 5 different test sessions.